Combining a ketogenic diet with cognitive training for blood cancer survivors
Official title: A Multi-component Non-pharmacological Intervention to Improve Cognitive Outcomes in Hematologic Cancer Survivors
Run by University of Alabama at Birmingham · NCT05708716 · Data updated 2026-11-12
This study is testing if a special diet combined with online brain training can help blood cancer survivors think better over 12 weeks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Birmingham, Alabama) |
| Status | Recruiting |
| Started | November 22, 2022 |
| Main results expected | December 31, 2026 |
| Study ends | April 30, 2027 |
| Registry record updated | December 17, 2025 |
| Trial ID | NCT05708716 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 21 and older who have been diagnosed with a hematologic malignancy and are experiencing mild to moderate cognitive impairment.
✕Probably not a fit
Patients with pre-existing neurological disorders, significant sensory impairments, or those who have participated in similar interventions recently may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the feasibility of a combined intervention program that includes a modified ketogenic diet and online cognitive training for survivors of hematologic malignancies. Participants will be randomized into two groups: one receiving the combined intervention for 12 weeks and a waitlist control group that will start the cognitive training after the wait period. The study will assess whether this intervention improves cognitive functioning compared to the control group and how long any effects may last. Safety and tolerability will be monitored throughout the trial.
Why it matters
Potential benefit: If successful, this intervention could enhance cognitive functioning in survivors of blood cancers, potentially improving their quality of life.
How similar studies have gone: While the combination of dietary interventions and cognitive training is innovative, similar approaches have shown promise in other populations, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult with hematologic malignancy diagnosed at age ≥21 years * Outpatient at least 3 months from completion of blood or marrow transplant (BMT) or at least 6 months from diagnosis for patients not treated with BMT * Evidence of mild-to-moderate cognitive impairment using either the Modified Telephone Interview for Mild Cognitive Impairment (TICS-M) or PROMIS 8a short form raw score = 19 -37 * Have daily access to an internet-connected home computer * Can fluently read and write in English * Can understand and sign the study-specific Informed Consent Form Exclusion Criteria: * History of pre-existing neurological disorder or documented major psychiatric disorder * Significant auditory, visual, or motor impairments * History of color blindness * Participated in neuropsychological intervention within the past 6 months * Evidence of active chronic graft vs. host disease (GvHD) for allogeneic BMT * History of pre-existing metabolic disease * Allergies to soy or milk * Body Mass Index (BMI) ≤20
Where it's running
-
University of Alabama at Birmingham
Birmingham, Alabama, United States Recruiting
Study contacts
- Principal investigator: Noha M Sharafeldin, MD, MSc, PhD — University of Alabama at Birmingham
- Study coordinator: Noha M Sharafeldin, MD, MSc, PhD
- Email: nsharafeldin@uabmc.edu
- Phone: 2056382144
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High-dose vs standard-dose flu vaccine in adults with blood cancers on B-cell-depleting therapy
This study tests whether a high-dose flu shot evokes a stronger immune response than a standard-dose shot in adults with hematologic cancers who recently had B-cell-depleting therapy.
-
Biomarkers That Signal Silent Strokes in High-Risk Cardiac Procedures
This study tests whether blood biomarkers NSE and NFLs can predict silent brain injuries and later cognitive problems in adults having high-risk transcatheter heart procedures.
-
Blood-based tests and digital cognitive checks to help triage dementia
This study tests whether adding blood biomarkers, APOE4 genetic info, and digital cognitive tests can help dementia diagnosis be faster in NHS Memory Clinics.
-
Cardiovascular and Cognitive Health Initiative
This study tests whether targeted cognitive and heart-health interventions can help improve thinking skills in adults with cardiovascular disease.
-
Synbiotic blend of LA-5 and agave inulin for mild cognitive impairment
This pilot crossover study tests whether a synbiotic containing Lactobacillus acidophilus LA-5 and agave inulin can help adults aged 60–75 with mild cognitive impairment.
-
Immediate vs progressive standing dual-task training for older adults with mild to moderate cognitive impairment
This study tests whether starting with immediate standing dual-task training is better or worse than progressively increasing the difficulty for older adults with mild to moderate cognitive impairment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.